RSS Feed
Genzyme's Termeer: Worst Biotech CEO of '09
Genzyme CEO Henri Termeer is Adam Feuerstein's Worst Biotech CEO of the Year for 2009.
12:31PM 11/17/09
Isis Cholesterol Drug Effective, but Safety a Worry: BioBuzz
Mipomersen lowers cholesterol but not without liver side effects.
10:56AM 11/17/09
InterMune Hep C Drug Hit With Liver Tox Worry: BioBuzz
Safety monitors force change to mid-stage study of ITMN-191
09:11AM 11/17/09
Poniard's CEO Pulls a Belichick: BioBuzz
Risky late-game call puts Poniard in a deep financial hole.
11:59AM 11/16/09
A Closer Look at Cardium's Wound-Healing Drug: BioBuzz
Is it the drug or the gel that worked best in a phase II study?
10:51AM 11/16/09
Cell Therapeutics Lavishes Free Stock on Execs: BioBuzz
'Retention' bonus awarded to CEO Jim Bianco, his management team and directors.
09:23AM 11/16/09
Poniard Cancer Drug Fails Pivotal Study: BioBuzz
Lung cancer drug picoplatin doesn't prolong survival in phase III study.
08:01AM 11/16/09
FDA Finds Garbage in Genzyme Drugs
Latest manufacturing snafu sends stock plunging.
01:25PM 11/13/09
Biotech Stock Mailbag: Cardium Therapeutics
The fall in Cardium shares might be related, at least partially, to what looks like so-so results from a phase IIb study announced on Oct. 14.
01:01PM 11/13/09
FDA Delays Cadence Drug Review: BioBuzz
IV Acetaminophen review pushed back to February 2010.
08:24AM 11/13/09
Connect with TheStreet